VX-661 |
1-(2,2-Difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1H-indol-5-yl]-cyclopropanecarboxamide |
(CAS 1152311-62-0) |
 |
Description: |
VX-661 is a second F508del CFTR corrector and is believed to help CFTR protein reach the cell surface.
A Phase II study is developing with VX-661 to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) effects of VX-661 alone and when coadministered with VX-770 in subjects with Cystic Fibrosis (CF) who are homozygous for the F508del-CFTR mutation.
|
Product No. |
KT00961 |
Product Name |
VX-661 |
Synonyms |
VX 661; VX661 |
Formal Name |
1-(2,2-Difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1H-indol-5-yl]-cyclopropanecarboxamide |
CAS Number |
1152311-62-0 |
Molecular Formula |
C26H27F3N2O6 |
Formula Weight |
520.50 |
Formulation |
A crystalline solid |
Purity |
98%min |
Stability |
2 years |
Storage |
-20°C |
Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
Price & Availability |
In Stock. Price Negotiated. |
|
Related Products: |
CFTR(inh)-172
GlyH-101
IOWH-032
Ivacaftor
Ivacaftor benzenesulfonate
Selinexor (KPT-330)
Ataluren (PTC124)
|
|